Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

FRESENIUS SE : NorldLB sticks Neutral

share with twitter share with LinkedIn share with facebook
08/05/2020 | 08:24am EDT

In a research note published by Holger Fechner, NorldLB gives a Neutral rating to the stock. The target price is still set at EUR 40.

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.31% 71.52 Delayed Quote.8.43%
FRESENIUS SE & CO. KGAA -1.36% 37.83 Delayed Quote.-24.61%

© MarketScreener with dpa-AFX Analyser 2020
share with twitter share with LinkedIn share with facebook
All news about FRESENIUS SE & CO. KGAA
09/23FRESENIUS SE : Buy rating from Goldman Sachs
MD
09/23FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reiterates its Buy rating
MD
09/23FRESENIUS SE : Receives a Buy rating from Berenberg
MD
09/23FRESENIUS SE : Barclays takes a positive view
MD
09/21FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
09/17FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
09/17FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from JP Morgan
MD
09/14FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
09/14FRESENIUS : 2021 DRG inflator for German hospitals set at 2.53%
PU
09/10FRESENIUS : Medical Care to issue bonds with a volume of 1 billion US-dollars
PU
More news
Financials
Sales 2020 36 670 M 42 662 M 42 662 M
Net income 2020 1 833 M 2 133 M 2 133 M
Net Debt 2020 22 941 M 26 689 M 26 689 M
P/E ratio 2020 11,5x
Yield 2020 2,20%
Capitalization 21 089 M 24 502 M 24 535 M
EV / Sales 2020 1,20x
EV / Sales 2021 1,09x
Nbr of Employees 302 846
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 52,04 €
Last Close Price 37,83 €
Spread / Highest target 90,3%
Spread / Average Target 37,6%
Spread / Lowest Target -36,3%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-24.61%24 502
AIER EYE HOSPITAL GROUP CO., LTD.57.97%29 036
IHH HEALTHCARE-4.39%10 995
RAMSAY HEALTH CARE LIMITED-6.41%10 843
BANGKOK DUSIT MEDICAL SERVICES0.00%9 994
TOPCHOICE MEDICAL CORPORATION94.39%9 366